Comis Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 50.00 K
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 495.46%
- Profit Growth 830.80%
- Ebitda 1315.70%
- Net Worth 56.86%
- Total Assets 26.14%
About Comis Biotech
Comis Biotech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 November 2017 (Seven years and three months 16 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Sachin Shinde, Ashok Jadhav, Mothabhau Khairnar, and One other member serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media
Corporate Identity Details
- CIN/LLPIN
U01100PN2017PTC173351
- Company No.
173351
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Comis Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Shinde  | Director | 25-Jan-2018 | Current |
| Ashok Jadhav | Director | 10-Nov-2017 | Current |
| Mothabhau Khairnar | Director | 10-Nov-2017 | Current |
| Vijay Kadam | Director | 10-Nov-2017 | Current |
Financial Performance of Comis Biotech.
Comis Biotech Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 495.46% increase. The company also saw a substantial improvement in profitability, with a 830.8% increase in profit. The company's net worth Soared by an impressive increase of 56.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Comis Biotech?
In 2019, Comis Biotech had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Growpure Farms Private LimitedSachin Shinde is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Comis Biotech?
Unlock and access historical data on people associated with Comis Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Comis Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Comis Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.